+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Colon Screening Market Size, Share & Trends Analysis Report by Type (Test, Product), Product (Colonoscopes, Sigmoidoscopes, CT Scanners, MRI), End-Use, and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 150 Pages
  • February 2025
  • Region: Global
  • Grand View Research
  • ID: 6056069
REQUEST CUSTOMIZATION
Description Jump to:
The Colon Screening Market was valued at USD 17.21 billion in 2024, and is projected to reach USD 22.21 billion by 2030, rising at a CAGR of 4.39%. The growing prevalence of colorectal cancer, increasing government initiatives to encourage cancer screening, and ongoing technological advancements in the market are major factors driving the market growth. According to CDC data published in June 2024, the prevalence of IBD in the U.S. is estimated between 2.4 and 3.1 million. Similarly, the worldwide prevalence of ulcerative colitis was expected to be 5 million in 2023.

The development of technologically advanced products in colon screening has significantly contributed to the market's growth. These innovations have enhanced diagnostic accuracy, improved patient comfort, minimized risks associated with traditional procedures, and enabled earlier detection of colon-related diseases, including cancer and polyps. For instance, in May 2024, FUJIFILM launched two innovative endoscopic imaging technologies: CAD EYE and SCALE EYE. CAD EYE is an AI-powered system designed to enhance the detection of colonic mucosal lesions such as polyps and adenomas during colonoscopy.

In addition, the increasing efforts by private and public players worldwide to increase awareness and accessibility of colon screening have further driven the market across different regions. For instance, in November 2024, Guam Regional Medical City introduced an advanced capsule endoscopy service funded by a grant from the USDA Rural Development Program. This innovative, minimally invasive diagnostic solution represents a significant advancement in gastrointestinal healthcare for Guam and the surrounding region, enhancing medical technology while prioritizing patient comfort. Such developments increase access to advanced diagnosis services, thus driving market growth.

Moreover, the widespread adoption of routine screening programs has an effective role in detecting cancers & precancerous polyps. In addition, advancements in colonoscopy technology, including AI-assisted detection, have improved diagnostic efficiency and patient outcomes. For instance, in December 2023, Medtronic expanded its artificial intelligence collaboration with Cosmo Pharmaceuticals, the developer of plug-in software designed to detect health issues during endoscopic examinations automatically.

Key players in the market are engaged in technological advancements, new product launches, and partnerships & collaborations to gain a higher market share. For instance, in February 2022, Medtronic collaborated with the American Society for Gastrointestinal Endoscopy (ASGE) to offer AI-powered colonoscopy technology for colorectal cancer screening in underserved communities of the U.S.

Colon Screening Market Report Highlights

  • Based on type, the test segment held the largest revenue share in the market in 2024. Rising demand for simple and non-invasive screening procedures is propelling the segment growth.
  • Based on end use, the hospital segment held the largest revenue share in the market in 2024, owing to the growing number of hospital admissions due to colon cancer and the rise in the adoption of cancer screening.
  • North America dominated the global market with a revenue share of 51.3% in 2024 due to the presence of a large number of major market players and the high adoption of advanced technologies.

This report addresses:

  • Market intelligence to enable effective decision-making.
  • Market estimates and forecasts from 2018 to 2030.
  • Growth opportunities and trend analyses.
  • Segment and regional revenue forecasts for market assessment.
  • Competition strategy and market share analysis.
  • Product innovation listings for you to stay ahead of the curve.
  • COVID-19's impact and how to sustain in this fast-evolving market.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Product outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Colon Screening Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising prevalence of colorectal diseases
3.2.1.2. Favorable government initiatives and reimbursement policies
3.2.1.3. Introduction of technologically advanced products
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulations
3.3. Colon Screening: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic Landscape
3.3.2.3. Social Landscape
3.3.2.4. Technological landscape
3.3.2.5. Legal Landscape
3.3.2.6. Environmental Landscape
3.4. Colon Screening Market Number of Procedures, 2018-2024
3.5. Colon Screening Market Pricing Analysis by Product
Chapter 4. Colon Screening Market Segment Analysis, by Type, 2018-2030 (USD Million)
4.1. Definition and Scope
4.2. Type Market Share Analysis, 2024 & 2030
4.3. Segment Dashboard
4.4. Global Colon Screening Market, by Type, 2018 to 2030
4.5. Test
4.5.1. Test Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5.2. Colonoscopy
4.5.2.1. Colonoscopy Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5.3. Capsule Endoscopy
4.5.3.1. Capsule Endoscopy Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5.4. Imaging Tests
4.5.4.1. Imaging Tests Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5.4.2. Virtual Colonoscopy
4.5.4.2.1. Virtual Colonoscopy Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5.4.3. Magnetic resonance colonography (MRC)
4.5.4.3.1. Magnetic resonance colonography (MRC) Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5.5. Others
4.5.5.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5.6. End Use, by Test
4.5.6.1. Hospitals
4.5.6.1.1. Hospitals Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5.6.2. Outpatient Facilities
4.5.6.2.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.6. Product
4.6.1. Product Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.6.2. Colonoscopes
4.6.2.1. Colonoscopes Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.6.3. Sigmoidoscopes
4.6.3.1. Sigmoidoscopes Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.6.4. CT Scanners
4.6.4.1. CT Scanners Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.6.5. Magnetic Resonance Imaging (MRI)
4.6.5.1. Magnetic Resonance Imaging (MRI) Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.6.6. End Use, by Product
4.6.6.1. Hospitals
4.6.6.1.1. Hospitals Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.6.6.2. Outpatient Facilities
4.6.6.2.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. Colon Screening Market Segment Analysis, by Region, 2018-2030 (USD Million)
5.1. Regional Market Share Analysis, 2024 & 2030
5.2. Regional Market Dashboard
5.3. Regional Market Snapshot
5.4. Colon Screening Market Share by Region, 2024 & 2030:
5.5. North America
5.5.1. North America colon screening market, 2018-2030 (USD Million)
5.5.2. U.S.
5.5.2.1. Key country dynamics
5.5.2.2. Regulatory framework
5.5.2.3. Competitive scenario
5.5.2.4. U.S. colon screening market, 2018-2030 (USD Million)
5.5.3. Canada
5.5.3.1. Key country dynamics
5.5.3.2. Regulatory framework
5.5.3.3. Competitive scenario
5.5.3.4. Canada colon screening market, 2018-2030 (USD Million)
5.5.4. Mexico
5.5.4.1. Key country dynamics
5.5.4.2. Regulatory framework
5.5.4.3. Competitive scenario
5.5.4.4. Mexico colon screening market, 2018-2030 (USD Million)
5.6. Europe
5.6.1. Europe colon screening market, 2018-2030 (USD Million)
5.6.2. UK
5.6.2.1. Key country dynamics
5.6.2.2. Regulatory framework
5.6.2.3. Competitive scenario
5.6.2.4. UK colon screening market, 2018-2030 (USD Million)
5.6.3. Germany
5.6.3.1. Key country dynamics
5.6.3.2. Regulatory framework
5.6.3.3. Competitive scenario
5.6.3.4. Germany colon screening market, 2018-2030 (USD Million)
5.6.4. France
5.6.4.1. Key country dynamics
5.6.4.2. Regulatory framework
5.6.4.3. Competitive scenario
5.6.4.4. France colon screening market, 2018-2030 (USD Million)
5.6.5. Italy
5.6.5.1. Key country dynamics
5.6.5.2. Regulatory framework
5.6.5.3. Competitive scenario
5.6.5.4. Italy colon screening market, 2018-2030 (USD Million)
5.6.6. Spain
5.6.6.1. Key country dynamics
5.6.6.2. Regulatory framework
5.6.6.3. Competitive scenario
5.6.6.4. Spain colon screening market, 2018-2030 (USD Million)
5.6.7. Norway
5.6.7.1. Key country dynamics
5.6.7.2. Regulatory framework
5.6.7.3. Competitive scenario
5.6.7.4. Norway colon screening market, 2018-2030 (USD Million)
5.6.8. Sweden
5.6.8.1. Key country dynamics
5.6.8.2. Regulatory framework
5.6.8.3. Competitive scenario
5.6.8.4. Sweden colon screening market, 2018-2030 (USD Million)
5.6.9. Denmark
5.6.9.1. Key country dynamics
5.6.9.2. Regulatory framework
5.6.9.3. Competitive scenario
5.6.9.4. Denmark colon screening market, 2018-2030 (USD Million)
5.7. Asia Pacific
5.7.1. Japan
5.7.1.1. Key country dynamics
5.7.1.2. Regulatory framework
5.7.1.3. Competitive scenario
5.7.1.4. Japan colon screening market, 2018-2030 (USD Million)
5.7.2. China
5.7.2.1. Key country dynamics
5.7.2.2. Regulatory framework
5.7.2.3. Competitive scenario
5.7.2.4. China colon screening market, 2018-2030 (USD Million)
5.7.3. India
5.7.3.1. Key country dynamics
5.7.3.2. Regulatory framework
5.7.3.3. Competitive scenario
5.7.3.4. India colon screening market, 2018-2030 (USD Million)
5.7.4. Australia
5.7.4.1. Key country dynamics
5.7.4.2. Regulatory framework
5.7.4.3. Competitive scenario
5.7.4.4. Australia colon screening market, 2018-2030 (USD Million)
5.7.5. South Korea
5.7.5.1. Key country dynamics
5.7.5.2. Regulatory framework
5.7.5.3. Competitive scenario
5.7.5.4. South Korea colon screening market, 2018-2030 (USD Million)
5.7.6. Thailand
5.7.6.1. Key country dynamics
5.7.6.2. Regulatory framework
5.7.6.3. Competitive scenario
5.7.6.4. Thailand colon screening market, 2018-2030 (USD Million)
5.8. Latin America
5.8.1. Brazil
5.8.1.1. Key country dynamics
5.8.1.2. Regulatory framework
5.8.1.3. Competitive scenario
5.8.1.4. Brazil colon screening market, 2018-2030 (USD Million)
5.8.2. Argentina
5.8.2.1. Key country dynamics
5.8.2.2. Regulatory framework
5.8.2.3. Competitive scenario
5.8.2.4. Argentina colon screening market, 2018-2030 (USD Million)
5.9. MEA
5.9.1. South Africa
5.9.1.1. Key country dynamics
5.9.1.2. Regulatory framework
5.9.1.3. Competitive scenario
5.9.1.4. South Africa colon screening market, 2018-2030 (USD Million)
5.9.2. Saudi Arabia
5.9.2.1. Key country dynamics
5.9.2.2. Regulatory framework
5.9.2.3. Competitive scenario
5.9.2.4. Saudi Arabia colon screening market, 2018-2030 (USD Million)
5.9.3. UAE
5.9.3.1. Key country dynamics
5.9.3.2. Regulatory framework
5.9.3.3. Competitive scenario
5.9.3.4. UAE colon screening market, 2018-2030 (USD Million)
5.9.4. Kuwait
5.9.4.1. Key country dynamics
5.9.4.2. Regulatory framework
5.9.4.3. Competitive scenario
5.9.4.4. Kuwait colon screening market, 2018-2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, by Key Market Participants
6.2. Company Categorization
6.3. Company Profiles
6.3.1. Olympus Corporation
6.3.1.1. Company overview
6.3.1.2. Financial performance
6.3.1.3. Platform benchmarking
6.3.1.4. Strategic initiatives
6.3.2. PENTAX Medical (Hoya Corporation)
6.3.2.1. Company overview
6.3.2.2. Financial performance
6.3.2.3. Platform benchmarking
6.3.2.4. Strategic initiatives
6.3.3. FUJIFILM Holdings Corporation
6.3.3.1. Company overview
6.3.3.2. Financial performance
6.3.3.3. Platform benchmarking
6.3.3.4. Strategic initiatives
6.3.4. Medtronic
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Platform benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Ambu A/S
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Platform benchmarking
6.3.5.4. Strategic initiatives
6.3.6. Baxter (Hillrom & Welch Allyn)
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Platform benchmarking
6.3.6.4. Strategic initiatives
6.3.7. EndoFresh (Daichuan medical)
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Platform benchmarking
6.3.7.4. Strategic initiatives
6.3.8. Bracco
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Platform benchmarking
6.3.8.4. Strategic initiatives
6.3.9. Varay Laborix
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Platform benchmarking
6.3.9.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 4 Global Colon Screening Market, by Region, 2018-2030 (USD Million)
Table 5 North America Colon Screening Market, by Country, 2018-2030 (USD Million)
Table 6 North America Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 7 U.S. Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 8 Canada Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 9 Mexico Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 10 Europe Colon Screening Market, by Country, 2018-2030 (USD Million)
Table 11 Europe Colon Screening Market, by End Use, 2018-2030 (USD Million)
Table 12 UK. Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 13 Germany Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 14 France Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 15 Italy Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 16 Spain Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 17 Denmark Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 18 Sweden Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 19 Norway Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 20 Asia Pacific Colon Screening Market, by Country, 2018-2030 (USD Million)
Table 21 Asia Pacific Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 22 Japan Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 23 China Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 24 India Colon Screening Market, by End Use, 2018-2030 (USD Million)
Table 25 Australia Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 26 Thailand Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 27 South Korea Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 28 Latin America Colon Screening Market, by Country, 2018-2030 (USD Million)
Table 29 Latin America Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 30 Brazil Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 31 Argentina Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 32 Middle East & Africa Colon Screening Market, by Country, 2018-2030 (USD Million)
Table 33 Middle East & Africa Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 34 South Africa Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 35 Saudi Arabia Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 36 UAE Colon Screening Market, by Type, 2018-2030 (USD Million)
Table 37 Kuwait Colon Screening Market, by Type, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Colon Screening market: outlook
Figure 9 Colon Screening competitive insights
Figure 10 Ancillary market outlook
Figure 11 Colon Screening market driver impact
Figure 12 Colon Screening market restraint impact
Figure 13 Porter’s Analysis
Figure 14 PESTLE Analysis
Figure 15 Colon Screening market: Type movement analysis
Figure 16 Colon Screening market: Type outlook and key takeaways
Figure 17 Test market estimates and forecast, 2018-2030
Figure 18 Colonoscopy market estimates and forecast, 2018-2030
Figure 19 Capsule Endoscopy market estimates and forecast, 2018-2030
Figure 20 Imaging Tests market estimates and forecast, 2018-2030
Figure 21 Virtual Colonoscopy market estimates and forecast, 2018-2030
Figure 22 Magnetic resonance colonography (MRC) market estimates and forecast, 2018-2030
Figure 23 Others market estimates and forecast, 2018-2030
Figure 24 By Test, Hospitals market estimates and forecasts, 2018-2030
Figure 25 By Test, Outpatient Facilities market estimates and forecasts,2018-2030
Figure 26 Product market estimates and forecast, 2018-2030
Figure 27 Colonoscopes market estimates and forecast, 2018-2030
Figure 28 Sigmoidoscopes market estimates and forecast, 2018-2030
Figure 29 CT Scanners market estimates and forecast, 2018-2030
Figure 30 Magnetic Resonance Imaging (MRI) market estimates and forecast, 2018-2030
Figure 31 By Product, Hospitals market estimates and forecasts, 2018-2030
Figure 32 By Product, Outpatient Facilities market estimates and forecasts,2018-2030
Figure 33 Global colon screening market: Regional movement analysis
Figure 34 Global colon screening market: Regional outlook and key takeaways
Figure 35 North America colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 36 Key country dynamics
Figure 37 U.S. colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 38 Key country dynamics
Figure 39 Canada colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 40 Key country dynamics
Figure 41 Mexico colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 42 Europe colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 43 Key country dynamics
Figure 44 UK colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 45 Key country dynamics
Figure 46 Germany colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 47 Key country dynamics
Figure 48 Spain colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 49 Key country dynamics
Figure 50 France colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 51 Key country dynamics
Figure 52 Italy colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 53 Key country dynamics
Figure 54 Norway colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 55 Key country dynamics
Figure 56 Denmark colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 57 Key country dynamics
Figure 58 Sweden colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 59 Asia Pacific colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 60 Key country dynamics
Figure 61 Japan colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 62 Key country dynamics
Figure 63 China colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 64 Key country dynamics
Figure 65 India colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 66 Key country dynamics
Figure 67 Australia colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 68 Key country dynamics
Figure 69 South Korea colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 70 Key country dynamics
Figure 71 Thailand colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 72 Latin America colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 73 Key country dynamics
Figure 74 Brazil colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 75 Key country dynamics
Figure 76 Argentina colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 77 MEA colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 78 Key country dynamics
Figure 79 South Africa colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 80 Key country dynamics
Figure 81 Saudi Arabia colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 82 Key country dynamics
Figure 83 UAE colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 84 Key country dynamics
Figure 85 Kuwait colon screening market estimates and forecasts, 2018-2030 (USD Million)
Figure 86 Key company categorization
Figure 87 Heat map analysis 2024

Companies Mentioned

The major companies profiled in this Colon Screening market report include:
  • Olympus Corporation
  • PENTAX Medical (Hoya Corporation)
  • FUJIFILM Holdings Corporation
  • Medtronic
  • Ambu A/S
  • Baxter (Hillrom & Welch Allyn)
  • EndoFresh
(Daichuan medical)
  • Bracco
  • Varay Laborix

Table Information

Report AttributeDetails
No. of Pages150
PublishedFebruary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 17.21 Billion
Forecasted Market Value ( USD ) by 2030 $ 22.21 Billion
Compound Annual Growth Rate4.3%
Regions CoveredGlobal
No. of Companies Mentioned8

Related Topics

Related Reports

Colon Screening Market Size and Growth Trends and Forecast Report 2025-2033 - Product Image

Colon Screening Market Size and Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • Global
From
Colorectal Cancer Screening and Diagnostic Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

Colorectal Cancer Screening and Diagnostic Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 183 Pages
  • Global
From
Cancer Diagnostics Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Cancer Diagnostics Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 140 Pages
  • Global
From
Gastrointestinal Diagnostics - Global Strategic Business Report - Product Image

Gastrointestinal Diagnostics - Global Strategic Business Report

  • Report
  • 478 Pages
  • Global
From
Solid Tumors 2025: Technologies, Diagnostics & Therapeutics (California, United States - November 20-21, 2025) - Product Image

Solid Tumors 2025: Technologies, Diagnostics & Therapeutics (California, United States - November 20-21, 2025)

  • Conference
  • 2 Days
  • Global
Copyright © 2002-2025 Research and Markets. All Rights Reserved.